William W. Lovette
Analyst · the company's website at www.pilgrims.com
Thank you, Dunham, and good morning, everyone. Thank you for joining us today. We generated $2.1 billion net revenue during the first quarter of 2015, resulting in an adjusted EBITDA of $364 million or 17.7% margins. Our net income of $204 million compared favorably to the same quarter of 2014 with 108% year-over-year increase. Adjusted earnings per share was $0.82 compared to $0.39 in the same quarter of last year. We're off to a great start for 2015 as our team has once again delivered strong results despite some export challenges during the quarter. Though we are pleased with the progress, we are not satisfied, and we'll continue to refine our portfolio model, which we believe will differentiate us from our peers. We think our unique strategy will give us the ability to outperform the industry in all periods, while giving us lower overall volatility and a more consistent performance over an extended period of time. To give you an example of this strategy, we'd like to highlight our presence in the small bird category. As you know, the industry as a whole has been shifting a greater proportion of production to large bird deboning. Over the past few years, small bird production has declined from about 40% of total head to about 20% currently according to industry reports. Despite this shift, we as a company have chosen to build a portfolio approach and continue to invest in our operations. In contrast to short-term thinking, we have maintained our exposure to small bird even as others have decided to pull back and convert to large bird deboning or a different category. As a result, we've strengthen our leadership into small bird and we are far more profitable than our nearest competitor. But we also have leading positions in big bird deboning and case-ready retail chicken and approximately 20% of our total sales in prepared foods. Despite being viewed as the single market, there are actually significant differences in supply and demand and operation of big bird and small bird. Also, pricing of different sizes of chicken can move independent of one another, which means our balanced strategy gives us an opportunity to profit from price demand movements in different segments while further reducing earnings volatility. Our forward-looking approach is playing out very well as small bird pricing has been edging higher over the past few quarters due to reduced supplies and strong demand. Margins on small birds have improved to the point where it is now more profitable for us on a relative basis compared to big bird and giving us a tailwind to our blended margins. This dynamic is yet another validation of the superior value of our portfolio strategy. We're also responding to increased demand for reducing antibiotic usage in poultry. In fact, we are already the largest ABF producer for some key customers in the U.S. and are aggressively migrating our production to have at least 25% of our chicken ABF certified by the end of 2018. We are currently only using antibiotic strictly for therapeutic purposes and working hard to eliminate antibiotics use in human medicine from our hatcheries over the next 18 months. We are doing more than our fair share as we believe in treating our chickens right, while meeting consumer demand and exceeding industry standards. We can also see our diversification efforts working well as we take advantage of the shift in U.S. demographics. More and more consumers are buying boneless leg meat and thighs. In order to meet this increasing demand, we are investing more in leg meat deboning capacity in our plants. For example, by the end of this year, we will have the capacity to debone over half -- one half of our large leg quarters. In addition, we'll process others than the whole legs for both domestic and export consumption. As we convert more of our production to ABF, we'll be able to sell an increasing amount of whole bird equivalence, which includes the back half for our premium and domestic markets. Therefore, altogether, we are in the process of a significant reduction in our dependence on commodity exports for leg quarters. And as a result, we expect to create higher margins. In keeping with our strategy to grow value-added export products, we continue to believe that foreign demand will continue to grow significantly in the coming years. To further our strategy of creating a more consistent earnings profile regardless of market conditions, we are pleased with the progress we're making with our prepared food sales and operations. Having reduced our sales footprint by eliminating SKUs, shuttering inefficient lines and simplifying our approach, we now have a sustainable base of business from which to grow and further support increasing demand from our key customers. Skilled foodservice, key broad-line distributors, key regional and national chain operators are among the key customer segments to which we are focusing resources. We're also taking advantage of strong Pierce Chicken brand equity in the supermarket deli segment by adding the ability to offer key customers a complete program of ready-to-eat Pierce brand chicken along with best-in-class quality fresh rotisserie birds for their delis and case-ready chicken products for fresh meat case. Our customers continue to tell us that Pilgrim's is their go-to chicken solution provider. And while this provides a sustainable benefit for them, it also gives us financial benefits over the long term in both strong and weak markets. To support this strategy, a significant portion of our CapEx spend for the next 2 years will be dedicated to equipment that will enhance our prepared foods capacity and efficiency, and increase our sales of boneless leg meat. This approach, combined with our enhanced agility to purchase more prepared foods raw materials from the market when financially beneficial, will create a more consistent earnings profile for our company. Our Mexican operations had another strong quarter despite the impact of the stronger dollar as consumers' demand for chicken continues to exceed our expectations. Prices started the year strongly in January then moderated slightly in February before rebounding in March. Pilgrim's locally produced volume in Mexico was up 4% compared to the same period in 2014. Q2 has started off on a very strong note as well and indicates a robust demand for chicken products in Mexico. That said, Mexico is still facing some issues with avian influenza, and authorities have recently informed of new outbreaks in the states of Puebla and Guerrero. Fortunately at this time, we have not seen any incidence of avian influenza at any of our Mexican facilities. However, we will not be complacent. We will remain vigilant in stepping up our straining efforts and other preventive measures to avoid the potential for AI spread to our own flocks. Construction at our Veracruz facility is proceeding as expected. Both feed mill and hatchery should start running by mid-May. This schedule puts us on track to begin the commercial production of live chickens around summer time frame and for the first chicken to hit the market in early September. On the Tyson Mexico acquisition, we're still awaiting final decision from the Mexican antitrust authorities but expect a resolution sometime during quarter 2. While we see robust demand from Mexico, which is Pilgrim's largest export destination, other areas of the world continue to show some weakness from the residual effects as a result of lower oil prices in 2014. Additionally, though current strength of the dollar has dampened international trade, we believe that even under these less favorable circumstances, our export product mix still represents a tremendous opportunity, and offers great value proposition to global consumers. We believe we will outperform the market, and our exports should remain relatively stable this year. Regarding high-path avian influenza impact on exports, while none of Pilgrim's U.S. operations have been directly affected by recent isolated incidence of high-path avian influenza in some U.S. states, several countries, nonetheless, currently maintain temporary bans on all U.S. chicken products, thus restricting our access to some key export markets including destinations like China and South Korea. Although we expect some of these bans to eventually be relaxed, many restrictions are largely to remain in place throughout the balance of 2015. We continue to be optimistic about our international export opportunities and see to impact from these bans is temporary. We do not foresee recent market volatility have any material or lasting effect on our mid- to long-term international prospects or ambition. Moving onto industry data. We expect no change to our previous outlook for 2015 on feed costs. Both corn and soybean meal should remain relatively benign and stable for the remainder of the year to a near-record existing stock levels and conservative worldwide planning expectations this year. Feed cost volatility should not be a determining factor in our ability to deliver good results this year. Regarding chicken production, we've seen the industry growing somewhat ahead of USDA's prior forecast mainly on weights. While there is some volatility in pullet data, some of the growth in recent pullet numbers can be explained by higher requirements to support hatching egg exports to Mexico and a replacement of the existing aging breeder flock. Additionally, on the operational side, the whole industry is currently operating at a very high capacity utilization rate, which constrains the ability to process the large increase in supply of birds within the short to medium term without significant investments in the whole value chain. We are also seeing higher demand than previously and therefore, believe supply and demand to remain in good balance this year. Poultry provides the best value relative to other options. Beef prices are expected to increase, even higher this grilling season versus last year's record levels, due to tighter supplies. Meanwhile, although pork production has grown year-over-year, retailers are not passing on the full savings to consumers. And as a result, chicken prices continue to remain very attractive. Breast meat and tenders have remain strong and are gaining momentum, and despite temporary uncertainties in export markets, cutouts have also remained higher than last year. Outside of leg quarters, cold storage inventory has remained low. We continue to see positive signs for demand, and chicken continues to be the best, best-value protein available for retail and foodservice. We believe our portfolio approach in fresh and prepared foods is relevant even in an environment where overall chicken supplies grow. Given our diversity in bird sizes, market segmentation and customer exposure, we are well positioned to benefit regardless of market conditions and outperform our peers with lower levels of earnings volatility. With that, I'd like to ask our CFO, Fabio Sandri to discuss our financial results.